Adenosine deaminase (ADA) is widely used in TB-endemic regions due to its low cost and high diagnostic accuracy, although its specificity may be reduced in certain conditions, such as empyema, lymphoma, and rheumatoid pleuritis. This evidence concerns the gene ADA and empyema.